BACKGROUND: Cancer leads to a complicated pattern of change in quality of life (QoL). OBJECTIVE: The aims of this study were to assess the impact of treatment-related side effects on QoL in cancer patients and to explore which other factors, and to what extent, contribute to explain low QoL scores. METHODS: One hundred twenty-three cancer patients receiving chemotherapy completed the self-administered questionnaires (Medical Outcomes Short-Form-36 (SF-36) and 12-item General Health Questionnaire). Multiple regression analyses were conducted with the SF-36 physical component summary (PCS) and SF-36 mental component summary (MCS) scores as the dependent variables and demographic and clinical factors as independent variables. RESULTS: Seventy-two percent of patients experienced treatment-related side effects, and 32% resulted positive for psychiatric diseases. Two multivariate analyses showed that worse PCS scores, like worse MCS scores, were significantly and independently predicted by treatment-related side effects (odds ratio (OR) = 5.00, 95%CI 1.29-19.45; OR = 8.08, 95%CI 2.03-32.22, respectively) and changes in health over the last 12 months (OR =2.34, 95%CI 1.47-3.76; OR = 3.21, 95%CI 1.90-5.41, respectively), after adjustment for age, gender, years of school, time from cancer diagnosis, and psychiatric disease. CONCLUSIONS: Given the new emphasis on QoL, we suggest that physicians have a responsibility to openly discuss therapy efficacy, prognosis as well as the potential for adverse events with their patients. Changes in health, as perceived by patient, should also be monitored at follow-up.
BACKGROUND:Cancer leads to a complicated pattern of change in quality of life (QoL). OBJECTIVE: The aims of this study were to assess the impact of treatment-related side effects on QoL in cancerpatients and to explore which other factors, and to what extent, contribute to explain low QoL scores. METHODS: One hundred twenty-three cancerpatients receiving chemotherapy completed the self-administered questionnaires (Medical Outcomes Short-Form-36 (SF-36) and 12-item General Health Questionnaire). Multiple regression analyses were conducted with the SF-36 physical component summary (PCS) and SF-36 mental component summary (MCS) scores as the dependent variables and demographic and clinical factors as independent variables. RESULTS: Seventy-two percent of patients experienced treatment-related side effects, and 32% resulted positive for psychiatric diseases. Two multivariate analyses showed that worse PCS scores, like worse MCS scores, were significantly and independently predicted by treatment-related side effects (odds ratio (OR) = 5.00, 95%CI 1.29-19.45; OR = 8.08, 95%CI 2.03-32.22, respectively) and changes in health over the last 12 months (OR =2.34, 95%CI 1.47-3.76; OR = 3.21, 95%CI 1.90-5.41, respectively), after adjustment for age, gender, years of school, time from cancer diagnosis, and psychiatric disease. CONCLUSIONS: Given the new emphasis on QoL, we suggest that physicians have a responsibility to openly discuss therapy efficacy, prognosis as well as the potential for adverse events with their patients. Changes in health, as perceived by patient, should also be monitored at follow-up.
Authors: Jordanka Kirkova; Lisa Rybicki; Declan Walsh; Aynur Aktas; Mellar P Davis; Matthew T Karafa Journal: Am J Hosp Palliat Care Date: 2010-12-08 Impact factor: 2.500
Authors: Penelope Schofield; Michael Jefford; Mariko Carey; Kathryn Thomson; Melanie Evans; Carl Baravelli; Sanchia Aranda Journal: Support Care Cancer Date: 2007-05-30 Impact factor: 3.603
Authors: E Dale Collins; Caroline P Moore; Kate F Clay; Stephen A Kearing; Annette M O'Connor; Hilary A Llewellyn-Thomas; Richard J Barth; Karen R Sepucha Journal: J Clin Oncol Date: 2008-12-29 Impact factor: 44.544
Authors: Maike G Sweegers; Laurien M Buffart; Wouke M van Veldhuizen; Edwin Geleijn; Henk M W Verheul; Johannes Brug; Mai J M Chinapaw; Teatske M Altenburg Journal: Oncologist Date: 2018-11-13
Authors: Ilufredo Y Tantoy; Bruce A Cooper; Anand Dhruva; Janine Cataldo; Steven M Paul; Yvette P Conley; Marilyn Hammer; Kord M Kober; Jon D Levine; Christine Miaskowski Journal: Qual Life Res Date: 2018-04-21 Impact factor: 4.147
Authors: Gwen Wyatt; Alla Sikorskii; Irena Tesnjak; David Victorson; Gordan Srkalovic Journal: Support Care Cancer Date: 2015-03-25 Impact factor: 3.603
Authors: Federica Mazzuca; Andrea Botticelli; Eva Mazzotti; Marco La Torre; Marina Borro; Luca Marchetti; Chiara Maddalena; Giovanna Gentile; Maurizio Simmaco; Paolo Marchetti Journal: Eurasian J Med Date: 2015-07-07
Authors: Caroline S Kampshoff; Femke Jansen; Willem van Mechelen; Anne M May; Johannes Brug; Mai J M Chinapaw; Laurien M Buffart Journal: Int J Behav Nutr Phys Act Date: 2014-07-02 Impact factor: 6.457
Authors: Jiil Chung; Girish S Kulkarni; Robin Morash; Andrew Matthew; Janet Papadakos; Rodney H Breau; David Guttman; Jackie Bender; Jennifer M Jones Journal: Support Care Cancer Date: 2019-02-14 Impact factor: 3.603
Authors: Lari Wenzel; Kathryn Osann; Chelsea McKinney; David Cella; Giulia Fulci; Mary J Scroggins; Heather A Lankes; Victoria Wang; Kenneth P Nephew; George L Maxwell; Samuel C Mok; Thomas P Conrads; Austin Miller; Robert S Mannel; Heidi J Gray; Parviz Hanjani; Warner K Huh; Nick Spirtos; Mario M Leitao; Gretchen Glaser; Sudarshan K Sharma; Alessandro D Santin; Paul Sperduto; Shashikant B Lele; Robert A Burger; Bradley J Monk; Michael Birrer Journal: J Natl Cancer Inst Date: 2021-10-01 Impact factor: 13.506
Authors: Petra G Puhringer; Alicia Olsen; Mike Climstein; Sally Sargeant; Lynnette M Jones; Justin W L Keogh Journal: PeerJ Date: 2015-11-10 Impact factor: 2.984